Shereen F. Mossallam

Alexandria, ALX, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Schistosoma mansoni egg-derived extracellular vesicles: A promising vaccine candidate against murine schistosomiasis.

Schistosoma mansoni egg-derived extracellular vesicles: A promising vaccine candidate against murine schistosomiasis.

Journal: PLoS neglected tropical diseases

Published: June 16, 2021

In vitro susceptibility of human Blastocystis subtypes to simeprevir.

In vitro susceptibility of human Blastocystis subtypes to simeprevir.

Journal: Saudi journal of biological sciences

Published: November 11, 2020

Repositioning of chlorambucil as a potential anti-schistosomal agent.

Repositioning of chlorambucil as a potential anti-schistosomal agent.

Journal: Acta tropica

Published: June 25, 2016

Evaluation of newly isolated probiotics in the protection against experimental intestinal trichinellosis.

Evaluation of newly isolated probiotics in the protection against experimental intestinal trichinellosis.

Journal: Veterinary parasitology

Published: March 21, 2015

Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni.

Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni.

Journal: Acta tropica

Published: August 24, 2014

Successful detection, expression and purification of the alternatively spliced truncated Sm14 antigen of an Egyptian strain of Schistosoma mansoni.

Successful detection, expression and purification of the alternatively spliced truncated Sm14 antigen of an Egyptian strain of Schistosoma mansoni.

Journal: Journal of helminthology

Published: July 25, 2014

Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.

Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.

Journal: BMC infectious diseases

Published: July 25, 2014

Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with a cystogenic ME49 strain of Toxoplasma gondii.

Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with a cystogenic ME49 strain of Toxoplasma gondii.

Journal: Acta tropica

Published: May 20, 2014

Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis.

Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis.

Journal: Experimental parasitology

Published: May 06, 2014

Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia.

Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia.

Journal: Experimental parasitology

Published: April 29, 2014

Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.

Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.

Journal: Experimental parasitology

Published: March 31, 2014

Potentiated anti-microsporidial activity of Lactobacillus acidophilus CH1 bacteriocin using gold nanoparticles.

Potentiated anti-microsporidial activity of Lactobacillus acidophilus CH1 bacteriocin using gold nanoparticles.

Journal: Experimental parasitology

Published: March 17, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026